Aurinia Pharmaceuticals Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
AUPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
#140, 14315 118 Avenue, Edmonton, Alberta, Canada

Insiders trading volume in the past year

Aurinia Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Peter Greenleaf Chief Executive Officer, Director $8.52M -$711K -7.7% Mar 6, 2024
Matthew Maxwell Donley EVP, Ops & Strategy $3.22M -$224K -6.51% Mar 6, 2024
Michael Robert Martin Chief Business Officer $2.92M Mar 2, 2023
Joseph M. Miller Chief Financial Officer $2.78M -$195K -6.56% Mar 6, 2024
Stephen P. Robertson EVP, General Counsel $2.49M -$323K -11.5% Mar 6, 2024
Scott Habig Chief Commercial Officer $2.42M -$283K -10.5% Aug 6, 2024
Volker Knappertz EVP, Research and Development $1.95M -$168K -7.94% Feb 27, 2024
Neil Solomons Chief Medical Officer $1.02M Mar 2, 2022
George M. Milne Jr Director $887K May 18, 2023
Robert Bindert Huizinga EVP of Research $781K Mar 2, 2022
David R.W. Jayne Director $255K -$28.4K -10% May 21, 2024
Daniel Billen Director $162K -$30.1K -15.7% May 21, 2024
Massimilano Colao Chief Commercial Officer $152K Mar 2, 2022
Joseph P. Hagan Director $135K May 18, 2023
R. Hector MacKay-Dunn Director $107K -$32.3K -23.2% May 21, 2024
Brinda Balakrishnan Director $101K -$2.99K -2.88% May 21, 2024
Jill Leversage Director $74.1K -$32.2K -30.3% May 21, 2024
Robert T. Foster Director Sep 21, 2023
Jeffrey A. Bailey Director Aug 18, 2023
Timothy P. Walbert Director May 18, 2022
Karen L. Smith Director Aug 18, 2023

Recent Insider Transactions by Companies or Individuals for Aurinia Pharmaceuticals Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.